Overview

Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes

Status:
Completed
Trial end date:
2004-01-19
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia and Oceania. The aim of this trial is to compare the efficacy and safety of human insulin produced by the current process and the NN729 process in type 1 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc